Current and historical daily PE Ratio for Supernus Pharmaceuticals Inc (
) from 2018 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Supernus Pharmaceuticals stock (LTS:0LB2) PE ratio as of Jun 10 2024 is 0.
More Details
Supernus Pharmaceuticals Inc (LTS:0LB2) PE Ratio (TTM) Chart
Supernus Pharmaceuticals Inc (LTS:0LB2) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1291
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Supernus Pharmaceuticals PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-10 | At Loss | 2024-04-05 | At Loss |
2024-06-07 | At Loss | 2024-04-04 | At Loss |
2024-06-06 | At Loss | 2024-04-03 | At Loss |
2024-06-05 | At Loss | 2024-04-02 | At Loss |
2024-06-04 | At Loss | 2024-04-01 | At Loss |
2024-06-03 | At Loss | 2024-03-29 | At Loss |
2024-05-31 | At Loss | 2024-03-28 | At Loss |
2024-05-30 | At Loss | 2024-03-27 | At Loss |
2024-05-29 | At Loss | 2024-03-26 | At Loss |
2024-05-28 | At Loss | 2024-03-25 | At Loss |
2024-05-24 | At Loss | 2024-03-22 | At Loss |
2024-05-23 | At Loss | 2024-03-21 | At Loss |
2024-05-22 | At Loss | 2024-03-20 | At Loss |
2024-05-21 | At Loss | 2024-03-19 | At Loss |
2024-05-20 | At Loss | 2024-03-18 | At Loss |
2024-05-17 | At Loss | 2024-03-15 | At Loss |
2024-05-16 | At Loss | 2024-03-14 | At Loss |
2024-05-15 | At Loss | 2024-03-13 | At Loss |
2024-05-14 | At Loss | 2024-03-12 | At Loss |
2024-05-13 | At Loss | 2024-03-11 | At Loss |
2024-05-10 | At Loss | 2024-03-08 | At Loss |
2024-05-09 | At Loss | 2024-03-07 | At Loss |
2024-05-08 | At Loss | 2024-03-06 | At Loss |
2024-05-07 | At Loss | 2024-03-05 | At Loss |
2024-05-06 | At Loss | 2024-03-04 | At Loss |
2024-05-03 | At Loss | 2024-03-01 | At Loss |
2024-05-02 | At Loss | 2024-02-29 | At Loss |
2024-05-01 | At Loss | 2024-02-28 | At Loss |
2024-04-30 | At Loss | 2024-02-27 | At Loss |
2024-04-29 | At Loss | 2024-02-26 | At Loss |
2024-04-26 | At Loss | 2024-02-23 | At Loss |
2024-04-25 | At Loss | 2024-02-22 | At Loss |
2024-04-24 | At Loss | 2024-02-21 | At Loss |
2024-04-23 | At Loss | 2024-02-20 | At Loss |
2024-04-22 | At Loss | 2024-02-19 | At Loss |
2024-04-19 | At Loss | 2024-02-16 | At Loss |
2024-04-18 | At Loss | 2024-02-15 | At Loss |
2024-04-17 | At Loss | 2024-02-14 | At Loss |
2024-04-16 | At Loss | 2024-02-13 | At Loss |
2024-04-15 | At Loss | 2024-02-12 | At Loss |
2024-04-12 | At Loss | 2024-02-09 | At Loss |
2024-04-11 | At Loss | 2024-02-08 | At Loss |
2024-04-10 | At Loss | 2024-02-07 | At Loss |
2024-04-09 | At Loss | 2024-02-06 | At Loss |
2024-04-08 | At Loss | 2024-02-05 | At Loss |
Supernus Pharmaceuticals Inc (LTS:0LB2) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Supernus Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US8684591089
Description